Supplementary Figure S1 -Validation of anti-Gabarap antibody.
Expression levels of BmAtg8-PE were monitored by using a commercial anti-Gabarap antibody.
This antibody was selected for two reasons: i) BmAtg8 belongs to the Gabarap protein family; and ii) sequence alignment of HsGabarap (NP_009209.1) and BmAtg8 (NP_001040244.1) proteins showed a 91% identity (a) . Western blot analysis demonstrated that the antibody specifically reacted with a B. mori Atg8 recombinant protein produced in BL21DE3/pET28+BmAtg8 bacteria and detected a 16-kDa band. By testing protein extracts obtained from silkworm midgut, the antibody recognised a 16-kDa band and a 14-kDa band that corresponded to BmAtg8 and BmAtg8-PE, respectively (b). 
A) Generation of dsRNA and administration protocol
dsRNA was generated by using T7 RiboMAX™ Express RNAi System (Promega, P1700). RNA quality and integrity were assessed by electrophoresis prior to administration to the larvae. Electroporation of the larvae was performed just after injecting dsRNA, by using an electric pulse generator (ECM 830, BTX, Holliston, MA, USA). The protocol was modified from Thomas 1 .
B) Results
The RNAi-mediated silencing approach did not succeed in giving a strong and reproducible reduction of gene expression in larvae treated with dsRNA. A nonsignificant decrease in gene expression was observed when dsRNA was injected into the haemocoel (procedure followed or not by electroporation) (a, b). Electroporation of the larvae after dsRNA injection slightly increased the efficiency of the silencing, but this treatment led to high levels of mortality.
Unfortunately, these results are in accordance with previous and current studies on Lepidoptera, where a high variability of success in gene silencing by RNAi has been recorded, the results are conflicting, and, conversely to other insect species, a standard procedure has not been established 
